Hayashi, Y., Tsukada, M., Shinoda, D., Matsui, M., Iwama, K., Kajiwara, K., & Kozai, Y. (2025). Combined Impact of Prior Polatuzumab Vedotin Plus Bendamustine and Rituximab Therapy and Myeloablative Conditioning on Early Post-Transplant BK Virus-Associated Hemorrhagic Cystitis. Journal of Hematology, 14(2), 66-73. https://doi.org/10.14740/jh2010